Our systems have detected that you are using a computer with an IP address located in the USA.
If you are currently not located in the USA, please click “Continue” in order to access our Website.

Local restrictions - provision of cross-border services

Swissquote Bank Ltd (“Swissquote”) is a bank licensed in Switzerland under the supervision of the Swiss Financial Market Supervisory Authority (FINMA). Swissquote is not authorized as a bank or broker by any US authority (such as the CFTC or SEC) neither is it authorized to disseminate offering and solicitation materials for offshore sales of securities and investment services, to make financial promotion or conduct investment or banking activity in the USA whatsoever.

This website may however contain information about services and products that may be considered by US authorities as an invitation or inducement to engage in investment activity having an effect in the USA.

By clicking “Continue”, you confirm that you have read and understood this legal information and that you access the website on your own initiative and without any solicitation from Swissquote.

Research Market strategy
by Swissquote Analysts
Asian stocks kicked off the week on a strong positive note; hopes for more policy support being pretty much the only explanation to the early week optimism.Shanghai’s Composite jumped more than 4% on a sudden peak in trading volumes, ...
Germany’s second-largest lender CommerzbankAG said that its chief executive and chairman have submitted their resignations, as the bank faces pressure from shareholder Cerberus Capital Management for a deep overhaul due to persistent poor performance. “Even if we made strategic progress, the...
Investors only had eyes for the 4.8 million rise in US nonfarm jobs last month, although the average earnings slipped 1.2% versus -0.8% expected by analysts and the jobless claims remained close to the 20 million mark.Meanwhile, the v...
Tesla Inc. (TSLA) shares rose 8% to close at a record $1,208.66 on Thursday, on the heels of better-than-expected second-quarter sales for the electric-car maker. It was the stock's third consecutive all-time high and fourth straight session in the black. Earlier Thursday, the company said that...
US indices finished mostly higher on Wednesday on promising Covid vaccine trial from Pfizer and BioNTech, that maintained the hope of having a vaccine by January and dashed worries regarding the mounting new infection cases in the US....
Researchers said an experimental coronavirus vaccine from Pfizer Inc. and partner BioNTech SE showed promising signs of working in an early-stage study. Healthy adult volunteers given the vaccine candidate had higher levels of antibodies four weeks after being vaccinated and seven days after...
Live chat